IRIS
FARINA, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 261
NA - Nord America 209
AS - Asia 147
Totale 617
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 209
SE - Svezia 110
IT - Italia 92
CN - Cina 79
SG - Singapore 55
RU - Federazione Russa 26
FI - Finlandia 12
IE - Irlanda 6
DE - Germania 5
GB - Regno Unito 4
PH - Filippine 4
IN - India 3
BE - Belgio 2
FR - Francia 2
IR - Iran 2
JP - Giappone 2
AM - Armenia 1
IL - Israele 1
NL - Olanda 1
UA - Ucraina 1
Totale 617
Salva come PNG Salva come JPEG
Città #
Shanghai 39
Singapore 37
Ashburn 23
Milan 21
Lawrence 20
Princeton 20
Boardman 17
New York 16
Moscow 14
Rome 13
Helsinki 12
Ancona 4
Dallas 4
Los Angeles 4
Quezon City 4
Seattle 4
Shenzhen 4
Ballincollig 3
Dublin 3
Guangzhou 3
Osimo 3
Poli 3
Pune 3
San Giuliano 3
Vittoria 3
York 3
Beijing 2
Bosco Chiesanuova 2
Castel Mella 2
Dalmine 2
Florence 2
Ghent 2
Honcho 2
San Antonio 2
Santa Clara 2
Verona 2
Amsterdam 1
Bologna 1
Giv‘atayim 1
Hangzhou 1
Isfahan 1
London 1
Modena 1
Nantong 1
Naples 1
Newark 1
Paris 1
San Mateo 1
Taizhou 1
Trentola-Ducenta 1
Trumbull 1
Turin 1
Washington 1
Weitang 1
Wuhan 1
Yerevan 1
Totale 323
Salva come PNG Salva come JPEG
Nome #
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 39
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 35
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 31
POS0726 POST-TRAUMATIC STRESS DISORDER AND QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CROSS SECTIONAL WEB SURVEY-BASED STUDY 31
Biobanking for COVID-19 research 30
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 29
Obesity and its role in the management of rheumatoid and psoriatic arthritis 29
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 28
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 26
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 23
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 23
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 23
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 22
COVID-19: Pharmacology and kinetics of viral clearance 22
Drug retention rates of biological agents in adult onset Still's disease 22
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 21
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 19
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 19
Current treatment options and safety considerations when treating adult-onset Still’s disease 19
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 19
Loss of circulating CD8+ CD161high T cells in primary progressive multiple sclerosis 18
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 16
Low prevalence of arrhythmias in clinically stable COVID-19 patients 16
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 15
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic 15
Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis 14
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort 13
Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle 12
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year 12
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 11
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature 10
Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease 9
Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study 9
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 8
Totale 688
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.469
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 2 7 1
2020/202119 1 0 3 1 0 6 4 1 0 0 2 1
2021/202248 1 0 12 14 2 0 1 1 6 7 0 4
2022/2023216 50 43 16 6 12 25 20 25 4 2 6 7
2023/2024242 11 26 32 27 26 28 14 27 0 4 13 34
2024/2025153 56 15 21 28 33 0 0 0 0 0 0 0
Totale 688